All‐cause and cause‐specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

BACKGROUND: Mortality is increased in rheumatoid arthritis (RA), mainly because of cardiovascular (CV) events, cancer and infections. Recent data suggest that treatment with tumour necrosis factor (TNF) antagonists may affect this trend. OBJECTIVE: To assess whether treatment with TNF antagonists is...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Carmona, Loreto, Descalzo, Miguel Ángel, Perez‐Pampin, Eva, Ruiz‐Montesinos, Dolores, Erra, Alba, Cobo, Tatiana, Gómez‐Reino, Juan J
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 2007
Soggetti:
Extended Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955107/
https://ncbi.nlm.nih.gov/pubmed/17324968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.067660
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi